Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127868721 | 12786872 | 1 | I | 2014 | 20160915 | 20160927 | 20160927 | EXP | FR-AFSSAPS-RN20161456 | FR-ALLERGAN-1669849US | ALLERGAN | 35.00 | YR | F | Y | 0.00000 | 20160927 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127868721 | 12786872 | 1 | PS | SEROPLEX TABLETS | ESCITALOPRAM OXALATE | 1 | Oral | 10 MG, BID | 21323 | 10 | MG | BID | |||||||
| 127868721 | 12786872 | 2 | SS | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | Oral | 1 G, BID | N | U | 0 | 1 | G | BID | |||||
| 127868721 | 12786872 | 3 | SS | CORTANCYL | PREDNISONE | 1 | Oral | 5 MG, BID | 0 | 5 | MG | BID | |||||||
| 127868721 | 12786872 | 4 | SS | TAHOR | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 127868721 | 12786872 | 5 | SS | THERALENE | TRIMEPRAZINE | 1 | Oral | 5 MG, BID | 0 | 5 | MG | BID | |||||||
| 127868721 | 12786872 | 6 | SS | TRIATEC (ACETAMINOPHENCODEINE PHOSPHATE) | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Oral | 5 MG, QD | 0 | 5 | MG | QD | |||||||
| 127868721 | 12786872 | 7 | SS | STILNOX | ZOLPIDEM TARTRATE | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 127868721 | 12786872 | 8 | SS | IXPRIM | ACETAMINOPHENTRAMADOL HYDROCHLORIDE | 1 | Oral | UNK | 0 | ||||||||||
| 127868721 | 12786872 | 9 | SS | INEXIUM | ESOMEPRAZOLE | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127868721 | 12786872 | 1 | Thymus disorder |
| 127868721 | 12786872 | 2 | Renal transplant |
| 127868721 | 12786872 | 3 | Renal transplant |
| 127868721 | 12786872 | 4 | Hypercholesterolaemia |
| 127868721 | 12786872 | 5 | Thymus disorder |
| 127868721 | 12786872 | 6 | Hypertension |
| 127868721 | 12786872 | 7 | Insomnia |
| 127868721 | 12786872 | 8 | Product used for unknown indication |
| 127868721 | 12786872 | 9 | Prophylaxis against gastrointestinal ulcer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127868721 | 12786872 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127868721 | 12786872 | Cough | |
| 127868721 | 12786872 | Cytomegalovirus test positive | |
| 127868721 | 12786872 | Inappropriate schedule of drug administration | |
| 127868721 | 12786872 | Interstitial lung disease | |
| 127868721 | 12786872 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127868721 | 12786872 | 1 | 2009 | 0 | ||
| 127868721 | 12786872 | 2 | 2002 | 20160830 | 0 | |
| 127868721 | 12786872 | 3 | 2002 | 0 | ||
| 127868721 | 12786872 | 4 | 2002 | 0 | ||
| 127868721 | 12786872 | 5 | 2002 | 0 | ||
| 127868721 | 12786872 | 6 | 2002 | 0 | ||
| 127868721 | 12786872 | 7 | 2009 | 0 | ||
| 127868721 | 12786872 | 8 | 2014 | 0 | ||
| 127868721 | 12786872 | 9 | 2014 | 0 |